Nektar Therapeutics Statistics

Total Valuation

LON:0UNL has a market cap or net worth of GBP 289.93 million. The enterprise value is 264.87 million.

Market Cap	289.93M
Enterprise Value	264.87M

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	12.30M
Shares Outstanding	n/a
Shares Change (YoY)	+9.53%
Shares Change (QoQ)	-1.25%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	16.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.29
PB Ratio	27.27
P/TBV Ratio	27.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.57
EV / Sales	4.12
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.92

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 13.59.

Current Ratio	3.24
Quick Ratio	3.11
Debt / Equity	13.59
Debt / EBITDA	n/a
Debt / FCF	-1.05
Interest Coverage	-5.07

Financial Efficiency

Return on equity (ROE) is -189.46% and return on invested capital (ROIC) is -31.27%.

Return on Equity (ROE)	-189.46%
Return on Assets (ROA)	-26.80%
Return on Invested Capital (ROIC)	-31.27%
Return on Capital Employed (ROCE)	-75.46%
Revenue Per Employee	1.11M
Profits Per Employee	-1.69M
Employee Count	61
Asset Turnover	0.27
Inventory Turnover	n/a

Taxes

Income Tax	-117,646
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +59.28% in the last 52 weeks. The beta is 0.58, so LON:0UNL's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	+59.28%
50-Day Moving Average	14.94
200-Day Moving Average	18.74
Relative Strength Index (RSI)	34.49
Average Volume (20 Days)	1,368

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.36

Income Statement

In the last 12 months, LON:0UNL had revenue of GBP 67.53 million and -102.97 million in losses. Loss per share was -7.37.

Revenue	67.53M
Gross Profit	50.38M
Operating Income	-108.23M
Pretax Income	-103.09M
Net Income	-102.97M
EBITDA	-105.74M
EBIT	-108.23M
Loss Per Share	-7.37

Full Income Statement

Balance Sheet

The company has 169.22 million in cash and 144.47 million in debt, giving a net cash position of 26.31 million.

Cash & Cash Equivalents	169.22M
Total Debt	144.47M
Net Cash	26.31M
Net Cash Per Share	n/a
Equity (Book Value)	10.63M
Book Value Per Share	0.86
Working Capital	123.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -136.90 million and capital expenditures -1.02 million, giving a free cash flow of -137.91 million.

Operating Cash Flow	-136.90M
Capital Expenditures	-1.02M
Free Cash Flow	-137.91M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.61%, with operating and profit margins of -160.27% and -152.49%.

Gross Margin	74.61%
Operating Margin	-160.27%
Pretax Margin	-152.66%
Profit Margin	-152.49%
EBITDA Margin	-156.59%
EBIT Margin	-160.27%
FCF Margin	n/a

Dividends & Yields

LON:0UNL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.53%
Shareholder Yield	n/a
Earnings Yield	-35.52%
FCF Yield	-47.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0UNL has an Altman Z-Score of -20.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-20.1
Piotroski F-Score	3